Present status of management of nasopharyngeal carcinoma

Expert Review of Anticancer Therapy

Volumn 1, Issue 1, 2001, Pages 134-141

  Wei, William I ^a   Sham, Jonathan S T ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Brachytherapy; Nasopharyngectomy; Nasopharynx cancer; Radiotherapy; Results; Salvage; Staging; Surgery

Indexed keywords

CISPLATIN; FLUOROURACIL; VIRUS DNA;

ADULT; AGED; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SIZE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG EFFICACY; ENDEMIC DISEASE; ENDOSCOPY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; MALE; NASOPHARYNX CARCINOMA; NECK CANCER; REVIEW;

EID: 0035557915     PISSN: 14737140     EISSN: None     Source Type: Journal    
DOI: 10.1586/14737140.1.1.134     Document Type: Review

References (61)

1. Cancer incidence in five continents
2. Nasopharyngeal carcinoma: An eval2uation of 209 patients
3. Detection of subclinical nasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy
4. Nasopharyngeal carcinoma: CT Evaluation of patterns of tumor spread
5. Carcinoma of the nasopharynx
6. Computed tomography evaluation of neck node metastases from nasopharyngeal carcinoma
7. The efficacy of fiberoptic endoscopic examination and biopsy in the detection of early nasopharyngeal carcinoma
8. Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma
9. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma
10. Prognostic value of paranasopharyngeal extension of nasopharyngeal carcinoma on local control and short-term survival
11. The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma
12. Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography
13. Nasopharyngeal carcinoma: The significance of neck node involvement in relation to the pattern of distant failure
14. A proposed modification of the Ho stage-classification for nasopharyngeal carcinoma
15. N-staging of nasopharyngeal carcinoma: Discrepancy between UICC/AJCC and Ho systems
16. Staging of nasopharyngeal carcinoma: From Ho's to the new UICC system
17. A comparison of staging systems for nasopharyngeal carcinoma
18. Comparison of AJCC 1988 and 1997 classifications for nasopharyngeal carcinoma
19. Prognostic factors in 677 patients in Singapore with nondisseminated nasopharyngeal carcinoma
20. Nasopharynx
21. Treatment of stage I nasopharyngeal carcinoma: Analysis of the pattern of relapse and the results of withholding elective neck irradiation
22. Carcinoma of the nasopharynx: Factors affecting prognosis
23. Three-dimensional intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: The University of California-San Francisco experience
24. Intensity-modulated radiation therapy in head and neck cancers: The Mallinckrodt experience
25. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma-treated during 1975-1985, overall survival and patterns of failure
26. Prognostic factors of nasopharyngeal carcinoma: A review of 759 patients
27. Analysis of 1379 patients with nasopharyngeal carcinoma treated by radiation
28. The effect of loco-regional control on distant metastatic dissemination in carcinoma of the nasopharynx: An analysis of 1301 patients
29. VUMCA I Trial: Preliminary results of a randomized trial comparing neoadjuvant chemotherapy (cisplatin, epirubicin, bleomycin) plus radiotherapy vs. radiotherapy alone in stage IV (≥ N2, M0) carcinoma: A positive effect on progression-free survival
30. Preliminary report of the Asian-Oceanian Clinical Oncology Association randomized trial comparing cisplatin and epirubicin followed by radiotherapy versus radiotherapy alone in the treatment of patients with nasopharyngeal carcinoma
31. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: Phase III randomized intergroup study 0099
32. Concurrent chemoradiotherapy followed by adjuvant chemotherapy in Asian patients with nasopharyngeal carcinoma: Toxicities and preliminary results
33. The value of clinical follow-up for local nasopharyngeal carcinoma relapse
34. Quantitative and temporal correlation between circulating cell-free Epstein-Barr virus DNA and tumor recurrence in nasopharyngeal carcinoma
35. Kinetic of plasma Epstein-Barr virus DNA during radiation therapy for nasopharyngeal carcinoma
36. Adjunctive chemotherapy to radical radiation therapy in the treatment of advanced nasopharyngeal carcinoma
37. Nasopharyngeal carcinoma: Treatment of neck node recurrence by radiotherapy
38. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma
39. Pathological basis of surgery in the management of postradiotherapy cervical metastasis in nasopharyngeal carcinoma
40. Carcinoma of the nasopharynx
41. Re-irradiation of recurrent nasopharyngeal carcinoma-treatment techniques and results
42. Temporal lobe and hypothalamic-pituitary dysfunctions after radiotherapy for nasopharyngeal carcinoma: A distinct clinical syndrome
43. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: Survival after local recurrence
44. Stereotactic radiosurgery as a salvage treatment for locally persistent and recurrent nasopharyngeal carcinoma
45. Split-palate approach for gold grain implantation in nasopharyngeal carcinoma
46. Long-term results of radioactive gold grain implantation for the treatment of persistent and recurrent nasopharyngeal carcinoma
47. High dose rate intracavitary brachytherapy in the treatment of nasopharyngeal carcinoma
48. Surgical options for continuing treatment of recurrent nasopharyngeal carcinoma
49. New approach to the nasopharynx: The maxillary swing approach
50. Maxillary swing approach for resection of tumors in and around the nasopharynx
51. Salvage surgery for recurrent primary nasopharyngeal carcinoma
52. Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type
53. A Phase II study of ifosfamide, 5-fluorouracil and leucovorin in patients with recurrent nasopharyngeal carcinoma previously treated with platinum chemotherapy
54. Phase II trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma
55. Surgical resection of pulmonary metastases from nasopharyngeal carcinoma
56. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study
57. Effects of cranial irradiation on hypothalamic-pituitary function - A 5-year longitudinal study in patients with nasopharyngeal carcinoma
58. Retrospective analysis of nasopharyngeal carcinoma treated during 1976-1985: Late complications following megavoltage irradiation
59. Radiotherapy for nasopharyngeal carcinoma: Shielding the pituitary may improve therapeutic ratio
60. Osteosarcoma of the maxilla in Hong Kong Chinese postirradiation for nasopharyngeal carcinoma